Stay updated on Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.

Latest updates to the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer build of the page. This change updates the page version without altering the displayed study details.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRecruitment status changed to closed with added guidance sections for joining and reading the study, and the Intervention/Treatment heading and revision label were updated to reflect the latest structure (v3.6.0).SummaryDifference0.5%

- Check23 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5 on the page, indicating a minor internal update to the study record. This change reflects version control rather than content changes to the study details.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page shows a revision tag updated from v3.5.3 to v3.5.4, representing an internal site version update rather than a change to the trial information.SummaryDifference0.2%

- Check66 days agoChange DetectedThe page revision indicator was updated from v3.5.2 to v3.5.3, reflecting a system/version change without affecting the underlying study record content.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.